Richard C. Yocum Email and Phone Number
Richard C. Yocum work email
- Valid
- Valid
- Valid
Richard C. Yocum personal email
- Valid
Dr. Yocum draws on extensive life science/healthcare experience comprising more than 27 years of biopharmaceutical industry experience in clinical drug development combined with 11 years of clinical practice of Internal Medicine, providing high quality consulting for the biopharmaceutical industry to expedite clinical drug development, minimize risk, & optimize results and the probability of successful new product approvals.• Strategic clinical & regulatory guidance for drug development• Acting Chief Medical Officer (CMO) for early-stage companiesClinical development plans, protocols, study reports, sections of INDs/NDAs and annual reports, etc.• Manuscripts, abstracts, & other medical writing• Program management• Due diligence for in-licensing & partnership opportunities• Medical monitoring & pharmacovigilanceDr. Yocum possesses a proven track record of success in 7 new product approvals, with diverse experience comprising small molecule drugs, large molecule biologics, a genetically-modified bacteria live biotherapeutic product, and some device clinical development. He brings direct hands-on experience in all phases of clinical development, including SPA, Scientific Advice, multiple IND submissions; Phase I, II, III, & IV trials, investigator-initiated studies, and lifecycle management; NDA and MAA submissions; & postmarketing pharmacovigilance.Dr. Yocum has been an integral participant in dozens of successful face-to-face FDA & EMEA/CHMP meetings across a range of therapeutic areas, including pre-IND, pre-IDE, end-of-Phase II, & pre-NDA meetings, SPA & has defended registration dossiers at two FDA advisory panel meetings & one CHMP Oral Hearing. He was the principal author of numerous clinical development plans, protocols, study reports, PSURs, DSURs, integrated summaries of safety and efficacy, and clinical sections of FDA briefing books, new INDs, IND and NDA annual reports, and successful NDA, NDS, and MAA submissions.Dr. Yocum is board-certified in general internal medicine and has authored/co-authored 58 publications/abstracts. He currently resides in San Diego, CA.
-
Consultant And Owner, RetiredYocum Biopharmaceutical Consulting May 2016 - PresentRichard Yocum draws on his extensive life science/healthcare experience, comprising more than 28 years of biopharmaceutical industry experience in clinical drug development combined with 11 years in the clinical practice of general Internal Medicine, providing high quality consulting for the biopharmaceutical industry to expedite clinical drug development, minimize risk, and optimize results and the probability of successful new product approvals.• Strategic clinical and regulatory guidance for drug development• Clinical development plans, protocols, study reports, sections of INDs/NDAs, etc.• Manuscripts, abstracts, and other medical writing• Program management• Clinical due diligence for in-licensing and partnership opportunities• Medical monitoring and pharmacovigilance
-
Rescue Member, Operations Leader, Medical Committee Chair, Past PresidentSan Diego Mountain Rescue Team Nov 2013 - PresentSDMRT is a professional, all-volunteer, nonprofit 501(c)(3) organization that is accredited by the Mountain Rescue Association (MRA) and dedicated to saving lives through search, rescue, and mountain safety education. SDMRT responds to search and rescue (SAR) operations throughout California. SDMRT works with various Sheriff’s departments, which are responsible for SAR activities in their individual counties, including the San Diego County Sheriff’s Department. Served on Board of Directors beginning Nov 2014, as member at large, VP and head of training, and President Nov 2016-2017. Rescue Member. Chair of Medical Committee. Operations Leader.
-
Search Manager, Search Management UnitSan Diego County Sheriff'S Department Mar 2019 - PresentGraduate of Cal OES Direction & Control of the Search Function, Extended Search Management (now Cal OES Advanced D&C), National SAR School for Inland Search Management courses, and NASAR CalTopo for SAR Mission Management courses.
-
Medical Committee MemberMountain Rescue Association Nov 2021 - PresentUsRepresenting more than 90 government authorized search and rescue unit across North America. -
President, Board Of Directors, Rescue Member, And Medical Committee ChairRiverside Mountain Rescue Unit Nov 2021 - PresentRMRU is a Riverside County Sheriff's Department volunteer, nonprofit search and rescue organization accredited by the Mountain Rescue Association (MRA) specializing in high angle rock, helicopter, and snow & ice rescues. -
Secretary And Board Member, Competitive Athlete RowerChinook Performance Racing Apr 2015 - PresentMillington, Maryland, UsChinook Performance Racing is a rowing team for master’s rowers with a mission to provide competent, athletic, self-motivated rowers from throughout North America with an opportunity to race on a team of like-minded athletes at the highest levels, nationally and internationally. Board member since April 2017. -
Rower, Past President, Vp, And TreasurerSan Diego Rowing Club Jan 1995 - PresentFounded in 1888, one of the oldest rowing clubs in the United States. -
Chief Medical OfficerSophiris Bio Corp Dec 2011 - May 2016Formerly known as Protox Therapeutics headquartered in Vancouver, Canada, Sophiris (Nasdaq: SPHS), a 10-employee company developing a genetically-engineered, naturally-occurring protein into a novel, highly-targeted therapeutic for the treatment of prostate diseases. Sophiris’ lead drug is PRX302 (topsalysin) for the treatment of benign prostatic hyperplasia (BPH) and focal therapy for localized prostate cancer.Chief Medical Officer (CMO)Responsible for oversight and execution of clinical development program.• Oversaw completion of ongoing Phase I-II BPH clinical trial.• Authored clinical study reports for Phase IIb (final report), Phase I-II, and Phase III BPH trials.• Principal author of manuscript for Phase IIb study.• Selected and led meetings of North American and European clinical experts’ advisory panels.• Authored an updated and completely revamped Investigator’s Brochure and 2 IB updates.• Authored 5 yearly DSURs.• Authored briefing books and served as lead in 2 FDA guidance/end-of-Phase II meetings.• Served as clinical lead in pre-Phase III meetings with MPA in Sweden, MHRA in the UK, MEB in The Netherlands, and BfArM in Germany.• Authored successful application to FDA waiver of thorough QT/QTc trial (TQT), sparing the expense and time for a dedicated TQT.• Responsible for the design of pathway to product approval and authored first Phase III BPH clinical protocol, and then oversaw conduct of that study, with successful outcome announced Nov. 2015.• Oversaw conduct of Phase IIa trial for focal therapy of localized prostate cancer, with positive preliminary results announced Jan. 2016.• Served as clinical contact for Japanese partner, Kissei Pharmaceuticals.
-
ConsultantYocum Biopharmaceutical Consulting Sep 2011 - Dec 2011
-
Vice President, Drug Development & Medical AffairsRockwell Medical Technologies, Inc. Feb 2009 - Sep 2011Wixom, Michigan, UsInnovative, 210-employee specialty pharma company (Nasdaq: RMTI) headquartered in Michigan and leading manufacturer and developer of renal drug therapies and critical products focused on improving the quality of care for dialysis patients. Reporting to CEO/President/Chairman and responsible for the full scope of clinical functions, including preclinical activities through Phase I-IV trial design and execution, clinical research (including human PK/PD), and data analysis and management. -
Consultant, Biopharmaceutical Drug DevelopmentYocum Biopharmaceutical Consulting Jan 2009 - Feb 2009
-
Vice President, Clinical Development & Medical AffairsHalozyme Therapeutics, Inc. Apr 2005 - Jan 2009San Diego, California, UsReported to CEO. On senior leadership team. • Built Clinical Develop & Med Affairs from 1 to 13-person group (3 MDs)• Clinical lead in 5 pre-IND & 1 pre-IDE FDA meetings• Opened IND in bladder cancer and prepared new IND for NME in solid tumors• Crafted clinical development plans in oncology, neurology, immunology, & endocrine/metabolism• Clinical lead interface with partner Baxter for postmarketing trials program/ product launch & for premarketed program, & with Roche on partnered program• Designed 18 clinical trials: 2 for Cumulase® 510(k)-approved for in vitro fertilization 4 for Chemophase® for non-muscle-invasive bladder cancer 4 for Hylenex (505b2-approved) for adult palliative care & pediatric hydration 4 for recombinant human hyaluronidase (rHuPH20), active ingredient in Hylenex, co-administered with bisphosphonates & monoclonal Abs Co-designed 3 for rHuPH20 with insulin products for diabetes Co-designed 1 for peglyated rHuPH20 for advanced cancer -
Vice President, Clinical Development & Medical AffairsChugai Pharma Usa May 2002 - Mar 2005Reported to CEO. On senior leadership team. Managed dept of 20 full-time employees (3 MDs) & up to 20 contracted• Due diligence for in-licensing opportunities• Investigational products: MRA (Actemra®, tocilizumab, humanized monoclonal Ab to IL-6-R) Phase I-II for multiple myeloma, Castleman’s, & SLE; planning for Phase III in RA & sJRA CAL (humanized monoclonal antibody to PTH-related protein) Phase I-II for breast cancer bone mets GM-611 (motilin receptor agonist) Phase IIb for diabetic gastroparesis & Phase IIa for irritable bowel syndrome BO-653 (LDL peroxidation inhibitor) in Phase IIb for prevention of restenosis of coronary artery stents MABON (recombinant human monoclonal IGM antibody to ganglioside) in R4 planning for IND in melanoma SMD (superpotent vitamin D analogue) in R4 planning for IND for topical treatment of psoriasis Negotiated successful outcome with FDA for NDA filing a cardiovascular product based on a single pivotal efficacy trial
-
Executive Medical DirectorLigand Pharmaceuticals Apr 1995 - May 2002Jupiter, Florida, Us• Physician Team Leader for oncology & dermatology Phase I, II, III, and IV trials• Clinical lead for multiple successful pre-IND, end-of-Phase II, pre-NDA, and NDA meetings with FDA, meeting with Canadian HPB, and multiple meetings with EMEA/CHMP, including formal Oral Hearing that led to reversal of a vote of two positives and 11 negatives to a unanimously positive decision• Lead clinical contact for 2 INDs held by NCI • Project Leader for launch of 1300-patient multinational pivotal trials in advanced NSCLC• Clinical due diligence leading to acquisition of two companiesLigand’s track record during my tenure was approval of 7 of 7 (100%) new drug registration dossiers, with an eighth under review: • Panretin gel in AIDS-Kaposi’s sarcoma (KS) NDA• ONTAK in cutaneous T-cell lymphoma (CTCL) BLA• Panretin gel in AIDS-KS NDS• Targretin capsules in CTCL NDA• Panretin gel in AIDS-KS MAA• Targretin gel in CTCL NDA• Targretin capsules in CTCL MAA -
Associate Medical DirectorGensia Sicor Inc Dec 1993 - Feb 1995• Authored Efficacy and Study Drug Concentration/Pharmacokinetic sections of clinical study report for 2,698 patient multicenter Phase III acadesine trial and authored study report for a 30-subject bioequivalence trial.• Safety monitoring and adverse event reporting of a 2,698 patient multicenter Phase III trial in CABG surgery and a multicenter Phase III trial in noncardiac surgery.
Richard C. Yocum Skills
Richard C. Yocum Education Details
-
Uc San Diego School Of MedicineInternal Medicine Residency -
The Johns Hopkins University School Of MedicineMd
-
Dartmouth CollegeChemistry Major
Frequently Asked Questions about Richard C. Yocum
What company does Richard C. Yocum work for?
Richard C. Yocum works for San Diego Mountain Rescue Team
What is Richard C. Yocum's role at the current company?
Richard C. Yocum's current role is Consultant, Biopharmaceutical Industry.
What is Richard C. Yocum's email address?
Richard C. Yocum's email address is rc****@****ail.com
What schools did Richard C. Yocum attend?
Richard C. Yocum attended Uc San Diego School Of Medicine, The Johns Hopkins University School Of Medicine, Dartmouth College.
What skills is Richard C. Yocum known for?
Richard C. Yocum has skills like Clinical Development, Clinical Trials, Immunology, Drug Development, Oncology, Cancer, Biopharmaceuticals, Biotechnology, Protocol, Drug Discovery, Fda, Pharmaceutical Industry.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial